Goldman Sachs Group Inc Repligen Corp Transaction History

Goldman Sachs Group Inc

$613 Billion
Q4 2024

A detailed history of Goldman Sachs Group Inc transactions in Repligen Corp stock. As of the latest transaction made, Goldman Sachs Group Inc holds 121,619 shares of RGEN stock, worth $17.7 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

121,619

Previous 243,004 49.95%

Holding current value

$17.7 Million

Previous $36.2 Million 51.59%

% of portfolio

0.0%

Previous 0.01%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 11, 2025	SELL	$123.41 - $160.92 $15 Million - $19.5 Million	-121,385 Reduced 49.95%	121,619 $17.5 Million
Q3 2024 Nov 14, 2024	SELL	$119.79 - $167.35 $7 Million - $9.78 Million	-58,431 Reduced 19.38%	243,004 $36.2 Million
Q2 2024 Aug 13, 2024	BUY	$120.0 - $182.95 $7.57 Million - $11.5 Million	63,104 Added 26.48%	301,435 $38 Million
Q1 2024 May 15, 2024	SELL	$170.78 - $208.42 $4.29 Million - $5.24 Million	-25,143 Reduced 9.54%	238,331 $43.8 Million
Q4 2023 Feb 13, 2024	SELL	$114.17 - $185.35 $4.14 Million - $6.72 Million	-36,271 Reduced 12.1%	263,474 $47.4 Million
Q3 2023 May 14, 2024	BUY	$138.78 - $176.51 $5.03 Million - $6.4 Million	36,271 Added 13.77%	299,745 $47.7 Million
Q3 2023 Nov 14, 2023	BUY	$138.78 - $176.51 $9.51 Million - $12.1 Million	68,506 Added 29.63%	299,745 $47.7 Million
Q2 2023 May 14, 2024	SELL	$138.42 - $180.31 $2.27 Million - $2.96 Million	-16,408 Reduced 6.63%	231,239 $32.7 Million
Q2 2023 Aug 14, 2023	SELL	$138.42 - $180.31 $2.27 Million - $2.96 Million	-16,408 Reduced 6.63%	231,239 $32.7 Million
Q1 2023 May 14, 2024	SELL	$154.26 - $198.1 $17.2 Million - $22.1 Million	-111,377 Reduced 31.02%	247,647 $41.7 Million
Q1 2023 May 11, 2023	SELL	$154.26 - $198.1 $17.2 Million - $22.1 Million	-111,377 Reduced 31.02%	247,647 $41.7 Million
Q4 2022 May 14, 2024	BUY	$162.42 - $220.56 $359,760 - $488,540	2,215 Added 0.62%	359,024 $60.8 Million
Q4 2022 Feb 13, 2023	BUY	$162.42 - $220.56 $359,760 - $488,540	2,215 Added 0.62%	359,024 $60.8 Million
Q3 2022 May 14, 2024	SELL	$160.42 - $256.21 $8.46 Million - $13.5 Million	-52,709 Reduced 12.87%	356,809 $66.8 Million
Q3 2022 Nov 10, 2022	SELL	$160.42 - $256.21 $8.46 Million - $13.5 Million	-52,709 Reduced 12.87%	356,809 $66.8 Million
Q2 2022 May 14, 2024	BUY	$140.68 - $188.02 $20.5 Million - $27.5 Million	146,044 Added 55.43%	409,518 $66.5 Million
Q2 2022 Aug 15, 2022	BUY	$140.68 - $188.02 $2.19 Million - $2.93 Million	15,567 Added 3.95%	409,518 $66.5 Million
Q1 2022 May 16, 2022	BUY	$161.19 - $257.96 $974,715 - $1.56 Million	6,047 Added 1.56%	393,951 $74.1 Million
Q4 2021 Feb 14, 2022	BUY	$247.59 - $304.47 $7.85 Million - $9.66 Million	31,711 Added 8.9%	387,904 $103 Million
Q3 2021 Nov 10, 2021	BUY	$194.77 - $324.21 $69.4 Million - $115 Million	356,193 New	356,193 $103 Million

Others Institutions Holding RGEN

# of Institutions

476

Shares Held

55.6M

Call Options Held

311K

Put Options Held

235K

View Full List

About REPLIGEN CORP

Ticker RGEN
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 55,491,200
Market Cap $8.09B
Description
Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....

More about RGEN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Goldman Sachs Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Goldman Sachs Group Inc with notifications on news.

Account

Goldman Sachs Group Inc Repligen Corp Transaction History